<DOC>
	<DOCNO>NCT02625376</DOCNO>
	<brief_summary>This interventional , prospective , randomize , comparative monocentric study aim evaluate safety efficacy Resveratrol reduce progression exudative Age-Related Macular Degeneration .</brief_summary>
	<brief_title>Resveratrol Exudative Age-Related Macular Degeneration</brief_title>
	<detailed_description>Interventional , prospective , randomize , comparative monocentric study aim evaluate safety efficacy Resveratrol reduce progression exudative Age-Related Macular Degeneration . Comparison incidence choroidal neaovascularization study group perform .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Men woman age 55 unilateral exudative AMD Visual acuity less equal 20/25 affect eye Allergy investigational product atrophic AgeRelated Macular Degeneration age relate maculopathy significant medium opacities Other retinal pathology ( diabetic retinopathy , high myopia , retinal dystrophy ) Recent Cataract surgery Previous history vitrectomy Acute chronic severe organ failure Present participation clinical research study</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>